ZIM LABORATORIES LIMITED (ZIMLAB) financials

ZIM LABORATORIES LIMITED (ZIMLAB) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1989, Zim LaboratoriesLtd manufactures formulation drugs andpre formulation ingredients in India andmarkets and sells these within and outside India[1]

Market Cap: ₹777Cr.
Current Price: ₹145
Stock P/E: 205
ROE: 1.66%
ROCE: 4.91%
Book Value: ₹53.5
Dividend Yield: 0.00%
52W High / Low: ₹160/59.3

In Jun 2026, ZIM LABORATORIES LIMITED (ZIMLAB) reported sales ₹93.05 Cr and net profit ₹-3.88 Cr.

Annual TTM: sales ₹392 Cr, net profit ₹4 Cr.

Shareholding: Promoters 30.30% (Sep 2026), FIIs 0.17% (Sep 2026), DIIs 1.19% (Sep 2026), Public 68.35% (Sep 2026), No. of Shareholders 13,057% (Sep 2026).

ZIMLAB quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	89.72	95.40	108.52	71.43	88.39	107.81	102.85	93.05
Expenses	81.32	83.63	93.28	67.10	82.21	95.31	96.27	90.65
Operating Profit	8.40	11.77	15.24	4.33	6.18	12.50	6.58	2.40
OPM %	9.36%	12.34%	14.04%	6.06%	6.99%	11.59%	6.40%	2.58%
Other Income	1.32	1.76	1.55	1.48	2.04	1.71	6.16	0.99
Interest	2.89	2.73	2.91	3.30	3.16	3.43	3.31	3.64
Depreciation	4.97	4.77	5.23	4.79	4.83	4.85	4.90	5.17
Profit before tax	1.86	6.03	8.65	-2.28	0.23	5.93	4.53	-5.42
Tax %	34.41%	27.86%	37.34%	-25.88%	47.83%	28.16%	27.37%	-28.60%
Net Profit	1.22	4.35	5.42	-1.69	0.12	4.26	3.28	-3.88
EPS in Rs	0.25	0.89	1.11	-0.35	0.02	0.87	0.61	-0.72
Raw PDF	—	—	—	—	—	—	—	—

ZIMLAB profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	274	304	329	397	365	376	370	392
Expenses	255	267	292	345	325	332	341	364
Operating Profit	20	37	38	51	40	43	30	28
OPM %	7%	12%	12%	13%	11%	12%	8%	7%
Other Income	5	-3	5	6	5	6	11	11
Interest	13	11	8	6	7	11	13	14
Depreciation	13	15	15	16	15	20	19	20
Profit before tax	-1	9	19	36	23	18	8	5
Tax %	-216%	35%	33%	30%	27%	33%	29%	—
Net Profit	2	6	13	25	17	12	6	4
EPS in Rs	0.36	1.15	2.67	5.13	3.44	2.41	1.12	0.78
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	—

ZIMLAB balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	16	16	16	16	49	49	49	54
Reserves	135	136	141	154	145	183	196	233
Borrowings	77	90	82	53	62	112	118	127
Other Liabilities	96	81	81	112	79	99	102	112
Total Liabilities	325	323	320	335	335	443	464	525
Fixed Assets	101	111	103	103	107	160	164	160
CWIP	13	10	10	11	26	40	66	89
Investments	5	8	8	8	8	8	13	18
Other Assets	206	194	199	213	193	234	222	258
Total Assets	325	323	320	335	335	443	464	525

ZIMLAB cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	37	21	32	47	35	11	51	48
Cash from Investing Activity	-23	-19	-6	-14	-35	-72	-41	-57
Cash from Financing Activity	-15	-2	-26	-33	1	60	-9	28
Net Cash Flow	-1	0	0	-0	1	-1	0	18
Free Cash Flow	19	7	26	32	-0	-61	13	12
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	90%	133%	90%	125%	82%	35%	114%	173%

ZIMLAB shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	33.26%	33.26%	33.26%	33.26%	33.26%	30.35%	30.36%	30.30%
FIIs	0.21%	0.01%	0.03%	0.00%	0.02%	0.00%	0.03%	0.17%
DIIs	0.24%	0.24%	0.24%	0.24%	0.20%	0.07%	1.34%	1.19%
Public	66.29%	66.49%	66.46%	66.52%	66.52%	69.57%	68.28%	68.35%
No. of Shareholders	17,450	17,448	16,641	17,282	17,251	16,636	14,510	13,057

ZIMLAB key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	99	84	77	90	81	100	91	91
Inventory Days	126	144	125	171	99	173	188	208
Days Payable	165	168	150	186	109	133	156	170
Cash Conversion Cycle	61	60	52	75	71	140	123	129
Working Capital Days	41	40	41	59	61	55	48	29
ROCE %	15%	5%	10%	12%	17%	10%	8%	5%

ZIMLABUpdated 18 Oct 2026, 0:56

Zim Laboratories Limited

ZIMLABUpdated 18 Oct 2026, 0:56

Market Cap

₹777Cr.

Current Price

₹145

High / Low

₹160/59.3

Stock P/E

205

ROE1.66%

ROCE4.91%

Book Value₹53.5

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 1989, Zim LaboratoriesLtd manufactures formulation drugs andpre formulation ingredients in India andmarkets and sells these within and outside India[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	67.01	1.73	62.47	0.63	3.66	-0.22	-36.36	-0.14	-0.03
Sep 2023	85.26	1.22	76.29	1.42	3.72	5.45	23.3	4.18	0.86
Dec 2023	95.82	1.7	84.64	1.11	3.58	7.01	31.1	4.83	0.99
Mar 2024	117.39	2.28	101.96	1.53	3.87	10.81	26.92	7.89	1.62
Jun 2024	82	2.86	74.12	0.98	4.92	1.08	30.56	0.76	0.16
Sep 2024	89.72	2.89	81.32	1.32	4.97	1.86	34.41	1.22	0.25
Dec 2024	95.4	2.73	83.63	1.76	4.77	6.03	27.86	4.35	0.89
Mar 2025	108.52	2.91	93.28	1.55	5.23	8.65	37.34	5.42	1.11
Jun 2025	71.43	3.3	67.1	1.48	4.79	-2.28	-25.88	-1.69	-0.35
Sep 2025	88.39	3.16	82.21	2.04	4.83	0.23	47.83	0.12	0.02
Dec 2025	107.81	3.43	95.31	1.71	4.85	5.93	28.16	4.26	0.87
Mar 2026	102.85	3.31	96.27	6.16	4.9	4.53	27.37	3.28	0.61
Jun 2026	93.05	3.64	90.65	0.99	5.17	-5.42	-28.6	-3.88	-0.72

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	266	10	278	2	7	-27	-19	-22	—
Mar 2016	268	14	238	-2	9	5	5	5	—
Mar 2017	235	10	203	5	9	18	-6	19	—
Mar 2018	272	9	238	9	10	24	24	18	—
Mar 2019	332	11	289	2	11	23	30	16	3.31
Mar 2020	274	13	255	5	13	-1	-216	2	0.36
Mar 2021	304	11	267	-3	15	9	35	6	1.15
Mar 2022	329	8	292	5	15	19	33	13	2.67
Mar 2023	397	6	345	6	16	36	30	25	5.13
Mar 2024	365	7	325	5	15	23	27	17	3.44
Mar 2025	376	11	332	6	20	18	33	12	2.41
Mar 2026	370	13	341	11	19	8	29	6	1.12
TTM	392	14	364	11	20	5	—	4	0.78

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	30.3%
FIIs	0.17%
DIIs	1.19%
Public	68.35%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	33.26%	0%	0%	66.74%
Mar 2024	33.26%	0.01%	0%	66.74%
Jun 2024	33.26%	0%	0%	66.74%
Sep 2024	33.26%	0%	0%	66.73%
Dec 2024	33.26%	0.21%	0.24%	66.29%
Mar 2025	33.26%	0.01%	0.24%	66.49%
Jun 2025	33.26%	0.03%	0.24%	66.46%
Sep 2025	33.26%	0%	0.24%	66.52%
Dec 2025	33.26%	0.02%	0.2%	66.52%
Mar 2026	30.35%	0%	0.07%	69.57%
Jun 2026	30.36%	0.03%	1.34%	68.28%
Sep 2026	30.3%	0.17%	1.19%	68.35%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	8	86	93	78	265	87	6	0	172	265
Mar 2016	8	91	96	61	256	92	3	0	161	256
Mar 2017	8	110	81	60	259	89	4	0	166	259
Mar 2018	8	128	81	80	297	94	8	0	195	297
Mar 2019	16	135	77	96	325	101	13	5	206	325
Mar 2020	16	136	90	81	323	111	10	8	194	323
Mar 2021	16	141	82	81	320	103	10	8	199	320
Mar 2022	16	154	53	112	335	103	11	8	213	335
Mar 2023	49	145	62	79	335	107	26	8	193	335
Mar 2024	49	183	112	99	443	160	40	8	234	443
Mar 2025	49	196	118	102	464	164	66	13	222	464
Mar 2026	54	233	127	112	525	160	89	18	258	525

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	—	—	—	—
Mar 2016	22	-12	-10	0
Mar 2017	32	-7	-25	0
Mar 2018	37	-26	-10	1
Mar 2019	37	-23	-15	-1
Mar 2020	21	-19	-2	0
Mar 2021	32	-6	-26	0
Mar 2022	47	-14	-33	0
Mar 2023	35	-35	1	1
Mar 2024	11	-72	60	-1
Mar 2025	51	-41	-9	0
Mar 2026	48	-57	28	18

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	111	120	137	119	99	84	77	90	81	100	91	91
Inventory Days	104	88	108	134	126	144	125	171	99	173	188	208
Days Payable	144	109	137	172	165	168	150	186	109	133	156	170
Cash Conversion Cycle	71	99	108	81	61	60	52	75	71	140	123	129
Working Capital Days	38	35	55	37	41	40	41	59	61	55	48	29
ROCE %	—	13%	14%	13%	15%	5%	10%	12%	17%	10%	8%	5%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of ZIM LABORATORIES LIMITED (ZIMLAB)?

The reported market capitalisation for ZIM LABORATORIES LIMITED (ZIMLAB) is ₹777Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of ZIMLAB?

The current price shown for ZIM LABORATORIES LIMITED (ZIMLAB) on Fincrux is ₹145 with a 52-week high/low of ₹160/59.3.

What is the P/E ratio of ZIM LABORATORIES LIMITED (ZIMLAB)?

The stock P/E for ZIM LABORATORIES LIMITED (ZIMLAB) is 205 on Fincrux, with ROE at 1.66% and ROCE at 4.91%.

What were ZIMLAB latest quarterly results?

For Jun 2026, ZIM LABORATORIES LIMITED (ZIMLAB) reported sales ₹93.05 Cr and net profit ₹-3.88 Cr (figures in ₹ crore unless noted).

What are ZIMLAB annual sales and net profit?

For TTM, ZIM LABORATORIES LIMITED (ZIMLAB) shows sales of ₹392 Cr and net profit of ₹4 Cr on the Fincrux profit & loss statement.

Who owns ZIM LABORATORIES LIMITED (ZIMLAB)?

Latest shareholding for ZIM LABORATORIES LIMITED (ZIMLAB) on Fincrux: Promoters 30.30% (Sep 2026), FIIs 0.17% (Sep 2026), DIIs 1.19% (Sep 2026), Public 68.35% (Sep 2026), No. of Shareholders 13,057% (Sep 2026).

Where can I find ZIM LABORATORIES LIMITED (ZIMLAB) financials?

ZIM LABORATORIES LIMITED (ZIMLAB) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show ZIMLAB balance sheet and cash flow?

Yes. The ZIM LABORATORIES LIMITED (ZIMLAB) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 0:56